| Literature DB >> 6679954 |
J Sisson, B Shapiro, W H Beierwaltes, M Nakajo, J Glowniak, T Mangner, J E Carey, D P Swanson, J Copp, W Satterlee.
Abstract
A new radiopharmaceutical, [131I]metaiodobenzylguandine, concentrates in some malignant pheochromocytomas. Five patients were treated with two to four doses of [131I]MIBG (99-197 mCi/dose). Two patients had substantial subjective and objective responses. [131I]MIBG is the first chemically synthesized radiopharmaceutical of complex molecular structure to reduce cancer.Entities:
Mesh：
Substances：
Year: 1983 PMID： 6679954
Source DB: PubMed Journal: Trans Assoc Am Physicians ISSN： 0066-9458